Departmental Funding

1026. Deputy Ken O'Flynn asked the Minister for Health whether any recommendations, observations, management letters, internal control issues, expenditure concerns, or governance issues arose from the 2022 Comptroller and Auditor General audit of the Treatment Abroad Scheme; and if she will provide a summary of each such matter and the action taken. [32590/26]

1027. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, Comptroller and Auditor General review, value-for-money review, or expenditure-control review of the Treatment Abroad Scheme has been completed since the 2022 audit; and if so, the date, scope, findings, and recommendations of each review. [32591/26]

1030. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, or review by the Comptroller and Auditor General has examined the financial recording, traceability, and year attribution of expenditure under the Treatment Abroad Scheme since 2020; if so, to provide the findings; and if not, whether such an audit will now be commissioned. [32599/26]

1031. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a patient-level dataset under the Treatment Abroad Scheme that links each individual approval to associated expenditure, treatment dates, and payment dates; and if not, how financial accountability and verification of expenditure is ensured. [32600/26]

1052. Deputy Ken O'Flynn asked the Minister for Health to identify the specific grade, title, and role of the individual or body within the HSE that has final authority to approve or refuse applications under the Treatment Abroad Scheme; and whether this authority is exercised by a single decision-maker or a panel-based process. [32631/26]

1053. Deputy Ken O'Flynn asked the Minister for Health to set out the formal governance structure underpinning decision-making under the Treatment Abroad Scheme, including any documented approval hierarchy, escalation pathways, or oversight committees. [32632/26]

1054. Deputy Ken O'Flynn asked the Minister for Health whether decisions to approve funding under the Treatment Abroad Scheme are subject to any form of independent clinical review, secondary validation, or administrative appeal prior to authorisation of expenditure. [32633/26]

1055. Deputy Ken O'Flynn asked the Minister for Health to detail the process by which independent medical advisors engaged by the HSE in respect of Treatment Abroad Scheme applications are selected, governed, and assessed for independence; and whether their advice is binding or advisory. [32634/26]

1056. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, or examination by the Comptroller and Auditor General has been conducted on the decision-making and approval processes under the Treatment Abroad Scheme since 2020; and if so, to provide details and findings. [32635/26]

1058. Deputy Ken O'Flynn asked the Minister for Health whether a standardised cost range or expected cost per patient is applied when approving applications under the Treatment Abroad Scheme; if not, how value for money is assessed at approval stage. [32650/26]

1062. Deputy Ken O'Flynn asked the Minister for Health whether any internal or external audit has been carried out specifically on expenditure under the Treatment Abroad Scheme for gender affirmation procedures. [32654/26]

1063. Deputy Ken O'Flynn asked the Minister for Health whether any independent clinical validation, separate from the referring consultant and MDT, is carried out by the HSE prior to approval of applications under the Treatment Abroad Scheme for surgical procedures not provided in the State. [32655/26]

1065. Deputy Ken O'Flynn asked the Minister for Health whether any audit or review has been conducted on approvals granted under the Treatment Abroad Scheme for gender-related surgical procedures since 2020. [32657/26]

1066. Deputy Ken O'Flynn asked the Minister for Health whether post-operative outcomes, complications, or follow-up care requirements are tracked for patients funded under the Treatment Abroad Scheme; if not, the rationale for the absence of such data. [32658/26]

1067. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted any value-for-money or clinical effectiveness assessment in respect of gender-related surgical procedures funded under the Treatment Abroad Scheme. [32659/26]

1165. Deputy Ken O'Flynn asked the Minister for Health the way in which value for money is assessed in respect of funding provided to the Institute of Public Health in the absence of defined performance indicators. [32900/26]

1168. Deputy Ken O'Flynn asked the Minister for Health whether funding provided to the Institute of Public Health is subject to periodic review or renewal based on performance outcomes. [32903/26]

1169. Deputy Ken O'Flynn asked the Minister for Health to provide the annual level of Exchequer funding allocated to the Institute of Public Health for each year since 2020. [32904/26]

1178. Deputy Robert O'Donoghue asked the Minister for Health the investment that has been allocated in recent years toward improving infrastructure, patient space and family facilities within a hospital (details supplied); and if she will make a statement on the matter. [32953/26]

403. Deputy Tom Brabazon asked the Minister for Children, Disability and Equality if an emergency funded plan will be introduced in the next budget to address the urgent housing and care needs of ageing parents caring for adult children with intellectual disabilities. [31597/26]

404. Deputy Tom Brabazon asked the Minister for Children, Disability and Equality the current level of funding allocated to disability housing supports; and whether additional ring-fenced funding will be committed to address the growing crisis in provision. [31598/26]

427. Deputy Paul Donnelly asked the Minister for Children, Disability and Equality the funding allocated to CDNTs in CHO9 in 2025 and 2026; and the estimated funding required to eliminate current waiting lists within this CDNT. [31796/26]

11. Deputy Barry Ward asked the Minister for Foreign Affairs and Trade the position regarding the mechanisms in place to support agencies under her remit with the increased costs of employing staff; and if she will make a statement on the matter. [31361/26]

12. Deputy Barry Ward asked the Minister for Foreign Affairs and Trade the position regarding the mechanisms in place to support agencies under her remit to manage the increase in the minimum wages in recent years; and if she will make a statement on the matter. [31379/26]

13. Deputy Barry Ward asked the Minister for Foreign Affairs and Trade the position regarding the mechanisms in place to support agencies under her remit to manage increasing operating costs including insurance, energy and fuel; and if she will make a statement on the matter. [31397/26]